Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aptorum Group Ltd Cl A (APM)

Aptorum Group Ltd Cl A (APM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,072
  • Shares Outstanding, K 3,572
  • Annual Sales, $ 1,300 K
  • Annual Income, $ -9,800 K
  • 60-Month Beta 0.10
  • Price/Sales 27.06
  • Price/Cash Flow N/A
  • Price/Book 2.17
Trade APM with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.40 +577.86%
on 03/05/24
17.49 -45.74%
on 03/06/24
+7.82 (+469.97%)
since 02/28/24
3-Month
1.35 +602.96%
on 02/07/24
17.49 -45.74%
on 03/06/24
+7.00 (+281.12%)
since 12/28/23
52-Week
1.35 +602.96%
on 02/07/24
17.49 -45.74%
on 03/06/24
+6.14 (+183.28%)
since 03/28/23

Most Recent Stories

More News
Aptorum Group Receives Nasdaq Notification of Minimum Stockholders’ Equity Deficiency

Regulatory News:

APM : 9.49 (+9.08%)
Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations Limited

Regulatory News:

APM : 9.49 (+9.08%)
Aptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business Update

Regulatory News:

APM : 9.49 (+9.08%)
Aptorum Group Enters into Letter of Intent and Term Sheet To Acquire U Group

Regulatory News:

APM : 9.49 (+9.08%)
Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma

Regulatory News:

APM : 9.49 (+9.08%)
Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus

Regulatory News:

APM : 9.49 (+9.08%)
Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China

Regulatory News:

APM : 9.49 (+9.08%)
Aptorum Group Regains Compliance with Nasdaq Minimum Bid Price and Receives Nasdaq Notification of Minimum Market Value of Publicly Held Shares Deficiency

Regulatory News:

APM : 9.49 (+9.08%)
Aptorum Group Limited to Hold Special Extraordinary Meeting of Shareholders on February 21, 2023

Regulatory News:

APM : 9.49 (+9.08%)
Aptorum Group Announces 1-for-10 Reverse Stock Split

Regulatory News:

APM : 9.49 (+9.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Aptorum Group Limited is a pharmaceutical company. It engaged in developing and commercializing therapeutic and diagnostic technologies to tackle unmet medical needs. The company's therapeutic and diagnostic project primarily includes neurology, infectious diseases, gastroenterology, oncology and other...

See More

Key Turning Points

3rd Resistance Point 11.43
2nd Resistance Point 10.65
1st Resistance Point 10.07
Last Price 9.49
1st Support Level 8.71
2nd Support Level 7.93
3rd Support Level 7.35

See More

52-Week High 17.49
Fibonacci 61.8% 11.32
Last Price 9.49
Fibonacci 50% 9.42
Fibonacci 38.2% 7.52
52-Week Low 1.35

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar